MoH delivering cost effective drug chain, assures Professor Lackson Kasonka

0
MINISTRY of Health (MoH) Permanent Secretary-Technical Services Lackson Kasonka at Lusaka Apex University (LAMU)

MoH delivering cost effective drug chain, assures Professor Lackson Kasonka

By Henry Chunza, Saeed Simon Banda and Derrick Sinjela

Permanent Secretary Technical Services (PS-TS) in the Ministry of Health Professor Lackson Kasonka says Government is committed to the provision of sufficient funding for good quality essential medicines and medical supplies which are professionally, efficiently and cost effectively procured, stored and distributed as close to the family as possible.

Officiating at a Thursday 19th – Friday, 20th January, 2023 two-day National Supply Chain Review Meeting (NSCRM) hosted at Mulungushi International Conference Centre Kenneth Kaunda New Wing (MICC-KKNW) in Lusaka, aiming at appraising the 2022 supply chain performance and highlight focus areas for 2023 supply chain expectations, Prof. Lackson Kasonka said government has realigned procurement function of medicines and medical supplies from Ministry of Health to the Zambia Medicines and Medical Supplies Agency (ZAMMSA) in order to improve efficiency and responsiveness in the chain of procurement of medicines and medical supplies.

Other strategies the government have put in place includes the establishment of the Medicines and Medical Supplies Fund to support the procurement of medicines and medical supplies for public health facilities, Establishment of National Health Insurance Management Agency (NHIMA) whose purpose, among others, is to pay for the cost of insured healthcare services accessed by the registered members.

Prof. Kasonka added that the accredited public and private health facilities are getting reimbursements for medicines and medical supplies that are on the approved list to assure commodity security and government has increased the medicines and medical supplies budgetary allocation from Zambian Kwacha ZMW1.4 billion for 2021 to a record high ZMW4.6 billion in the 2023.

Kasonka reiterated a vow placing high premium on consistent disbursement of grants to Hospitals and Districts and subsequent increase of the emergency procurement threshold from four cent (4%) for Districts and 10% for Hospitals to thirty per cent (30%).

“These measures are expected to translate into improved availability of medicines and medical supplies in our facilities. Government will support improvements and strategies in distribution models for ZAMMSA to ensure availability and access of medicines and medical supplies in facilities and to achieve this, 7 regional hubs have been constructed in various provinces and three (3) more hubs are under construction in Lusaka, Northern and Central Provinces,” explained Prof. Kasonka.

The PS also said that government through the Zambia Medicines Regulatory Authority has expanded the national laboratory presence and is in the process of attaining World Health Organization (WHO) pre-qualification status in order to ensure quality provision of medicines and medical supplies.

“To improve resilience and efficiency of our supply chain, Zambia´s Government has identified the pharmaceutical industry as a priority as part of its post-pandemic approach to increasing health security and its endeavours to promote private sector driven socio-economic development and this effect, government has appointed the Zambia Pharmaceutical Manufacturing Steering Committee whose objective among others is to strengthen the local pharmaceutical manufacturing of medicines and medical supplies. So far, the Committee has set the Technical Working Group (TWG) which has been in meeting for over 4 months culminating into the launch of The Zambia Pharmaceutical Manufacturing Initiative (ZPMI) which was launched by the Minister responsible for Health on 20th October, 2022,” assured Prof. Kasonka

Prof. Kasonka also announced that on March 1-2 of 2023, the ZPMI will hold the Zambia – European Union Pharmaceutical Manufacturing Forum that will bring together representatives from EU and Zambian private sector parties to discuss opportunities for partnerships and provide insights that can help drive investment in Zambia’s pharmaceutical industry, to be graced by President Hakainde Hichilema and Health Minister, Ms. Sylvia Tembo-Masebo.

“To improve coordination amongst all players in the supply chain, the Ministry of Health has established the National Supply Chain Coordination Unit (NSCCU) – Control Tower which is expected to, among other functions, improve coordination of all supply chain partners, Prof. Kasonka added.

And Prof. Kasonka urged all stakeholders to participate fully and contribute to the improvement in the supply oversight by Ministry of Health on key supply chain functions such as ‘Quantification of Medicines’ and ‘Medical Supplies and Partners to strengthen MoH sustainability agenda in the supply chain, including curbing pilferage of medicines and medical supplies in public health facilities.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may have missed

绝妙集团公布50亿美元投资计划​作者:海伦·博瓦利亚(Hellen Bwalya)​绝妙集团有限公司(Wonderful Group of Companies Limited)通过其子公司赞比亚联合资本化肥有限公司(United Capital Fertilizer Zambia Company Limited),在其工业园区举行的奠基仪式上,正式启动了一项跨越2025年至2030年的50亿美元中长期工业投资宏伟计划。集团首席执行官黄耀弛先生在致答谢词时强调,该举措巩固了集团致力于提升赞比亚经济潜力、农业发展和就业水平的长期承诺。本次活动展示了多项价值数亿美元的制造业扩建及基础设施升级项目,旨在将赞比亚打造成中东非地区的核心工业强国。​在这项50亿美元的投资承诺中,园区内大规模的化工与化肥厂建设处于核心地位。继投资6.8亿美元的一期尿素生产厂竣工并投入运营后,集团正在稳步推进投资3.00亿美元的农化磷肥厂建设,预计将于第一季度投产,用于生产专用二铵(DAP)化肥。进一步的扩建计划还包括投资16亿美元的二期尿素项目和投资7.00亿美元的磷肥扩建项目,同时集团还将努力吸引更多绿色与高新技术投资者入驻运营。​为了支持这一工业增长并优化大宗运输物流,绝妙集团宣布了多项基础设施升级计划,包括升级连接当地矿山并穿过该工业园区的区域铁路网络、将蒙格维路(Mungwi Road)的部分路段改造为双向四车道,以及拓宽通往蒙布瓦路(Mumbwa Road)的连接线。这些基础设施项目将在完成内部财务手续后,通过政府与社会资本合作(PPP)模式实施,以畅通交通流量并缩短物资交付时间。黄耀弛先生对关键金融合作伙伴表达了谢意,向由艾莎银行(Absa Bank PLC)和赞比亚国家商业银行(ZANACO Bank PLC)牵头的银行银团为相关建设提供资金支持致以深切感谢。​在澄清公司身份时,黄耀弛先生指出,尽管早期外界存在误解,但绝妙集团和联合资本化肥公司均是值得骄傲的赞比亚本土企业。他强调,管理层中仅有两名中国籍员工,且均未直接参与日常运营,企业的行政控制权与管理权完全掌握在赞比亚本地人手中。黄耀弛先生重申了集团的承诺,并对赞比亚实现自产自销、对外出口以及引领东非和南部非洲工业未来的能力表达了坚定信心。